News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NuPathe Inc. (PATH) Cuts 50 Pct. of Jobs to Conserve Cash



10/9/2012 6:51:31 AM

NuPathe Inc (PATH.O: Quote) said it would cut half of its workforce to reduce costs and focus on the regulatory approval of its experimental migraine patch. The company said it will reduce expenses related to the marketing of the pain patch and on earlier-stage drug candidates. NuPathe has 37 employees, according to Thomson Reuters data. It also plans to delay the application for its experimental treatment for schizophrenia and bipolar disorder until it finds a partner. NuPathe is trying to raise about $28 million in a proposed financing and expects the cost cut initiatives, along with the proceeds, to be sufficient to fund operations into the fourth quarter of 2013.

Read at Reuters
Read at Street Insider


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES